Cytotoxic agents for the treatment of cancer
AssigneeCytRx Corporation
InventorDaniel Levitt
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method of treating brain cancer comprising administering a therapeutically effective substance to a patient, wherein the therapeutically effective substance comprises: (I), or a pharmaceutically acceptable salt thereof, wherein X is a. moiety that can be cleaved hydrolytically or enzymatically in the body of the patient in a pH-dependent manner.
Claims10
A method for the treatment of brain cancer comprising administering a therapeutically effective substance to a patient, wherein the therapeutically effective substance comprises DOXO-EMCH or a pharmaceutically acceptable salt thereof, wherein the therapeutically effective substance binds to serum albumin;
- and wherein the therapeutically effective substance is administered to the patient by an administration route selected from the group consisting of intravenous, intra-arterial and intramuscular.
Dependencies are inferred from the claim text.